# Jens Bager

> Jens Bager is a Series B investor at Impilo (Copenhagen) backing Biopharma and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Impilo](https://shizune.co/investors/profile/impilo)
- Location: Copenhagen, Denmark
- Total investments: 2
- Last investment: Jan 2011
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jensbager-dk

Jens Bager is a Series B investor at Impilo in Copenhagen focused on Biopharma and Health Care. Jens Bager - Chairman and Investor @ Scantox

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Health Diagnostics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DBV Technologies | DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapythat aims to activate the immune system of patients through the skin. | $25.5M | Series C | Jan 05, 2011 |  |
| DBV Technologies | DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapythat aims to activate the immune system of patients through the skin. | $6.6M | Series B | Jan 22, 2009 |  |

2 of 2 investments shown.

## Co-investors
- [Sofinnova Partners](https://shizune.co/investors/profile/sofinnova-partners) — VC Fund, 2 deals together
- [Alto Invest](https://shizune.co/investors/profile/alto-invest) — VC Fund, 1 deal together
- [InnoBio Fund](https://shizune.co/investors/profile/innobio-fund) — VC Fund, 1 deal together
- [Lundbeckfonden Ventures](https://shizune.co/investors/profile/lundbeckfond-ventures) — VC Fund, 1 deal together

## About Impilo

VC Fund · Stockholm, Sweden

Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.

5 contacts available at Impilo.

| Name | Title | Profile |
| --- | --- | --- |
| Jesper Eliasson | Partner & CFO | https://shizune.co/investors/profile/jesper-eliasson |
| Jens Bager | Industrial Partner | https://shizune.co/investors/profile/jens-bager |
| Magnus Edlund | Partner | https://shizune.co/investors/profile/magnus-edlund-0b36 |
| Martin Fagerlund | Partner & COO | https://shizune.co/investors/profile/martin-fagerlund-389d |
| Sören Mellstig | Co-founder | https://shizune.co/investors/profile/s%C3%B6ren-mellstig |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jens Bager invest in?

Jens Bager invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jens Bager last invest?

The most recent investment recorded for Jens Bager closed in Jan 2011. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co